Stock VICP VICAPSYS LIFE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Vicapsys Life Sciences, Inc.

Equities

VICP

US92560A1060

Delayed OTC Markets
Other stock markets
 15:29:14 10/05/2024 BST 		5-day change 1st Jan Change
0.444 USD 0.00% Intraday chart for Vicapsys Life Sciences, Inc. 0.00% -83.80%
2023 Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Vicapsys Life Sciences, Inc. announced that it has received $0.3036 million in funding
CI
Vicapsys Life Sciences, Inc. announced that it expects to receive $0.3036 million in funding
CI
Vicapsys Life Sciences : Change in Certifying Accountants - Form 8-K
PU
VICAPSYS LIFE SCIENCES, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
AQ
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Vicapsys Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt
CI
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
NOTE 2 - GOING CONCERN AND MANAGEMENT'S PLANS
AQ
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
Vicapsys Life Sciences, Inc. Announces Board Changes
CI
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Vicapsys Life Sciences, Inc. Appoints Federico Pier as Chief Executive Officer
CI
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VICP Stock
  4. News Vicapsys Life Sciences, Inc.